Exact Mass: 273.2308

Exact Mass Matches: 273.2308

Found 118 metabolites which its exact mass value is equals to given mass value 273.2308, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fenpropidin

1-(2-Methyl-3-(4-(2-methyl-2-propanyl)phenyl)propyl)piperidine

C19H31N (273.2456)


CONFIDENCE standard compound; INTERNAL_ID 8461 CONFIDENCE standard compound; INTERNAL_ID 2589 D016573 - Agrochemicals D010575 - Pesticides

   

C16 Sphinganine

2-aminohexadecane-1,3-diol

C16H35NO2 (273.2668)


   

N-Isobutyl-2,4,8,10,12-tetradecapentaenamide

(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO (273.2093)


N-Isobutyl-2,4,8,10,12-tetradecapentaenamide is found in herbs and spices. N-Isobutyl-2,4,8,10,12-tetradecapentaenamide is a constituent of Zanthoxylum piperitum (Japanese pepper tree) and other Zanthoxylum species Constituent of Zanthoxylum piperitum (Japanese pepper tree) and other Zanthoxylum subspecies N-Isobutyl-2,4,8,10,12-tetradecapentaenamide is found in herbs and spices.

   

Heptanoylcarnitine

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


Heptanoylcarnitine is an acylcarnitine. More specifically, it is an heptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Heptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine heptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

4-Methylhexanoylcarnitine

3-[(4-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


4-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methylhexanoylcarnitine

3-[(5-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


5-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylhexanoylcarnitine

3-[(3-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


3-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine

1-[1-(3-methoxyphenyl)cyclohexyl]piperidine

C18H27NO (273.2093)


   

4-Methoxyphencyclidine

4-methoxy-1-(1-phenylcyclohexyl)piperidine

C18H27NO (273.2093)


   

gamma-Sanshool

N-(2-Methylpropyl)tetradeca-2,4,8,10,12-pentaenimidate

C18H27NO (273.2093)


   
   

Mirabilin G

Mirabilin G

C17H27N3 (273.2205)


   
   

1-(1-(4-Methoxyphenyl)cyclohexyl)piperidine

1-(1-(4-Methoxyphenyl)cyclohexyl)piperidine

C18H27NO (273.2093)


   

3-meo-pcp

1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine

C18H27NO (273.2093)


   

N-Lauryldiethanolamine

N-Lauryldiethanolamine

C16H35NO2 (273.2668)


   

tetradeca-2E-ene-10,12-diynoic acid isobutylamide

tetradeca-2E-ene-10,12-diynoic acid isobutylamide

C18H27NO (273.2093)


   

2,4,10-Tetradecatrien-8-ynoic acid isobutylamide

2,4,10-Tetradecatrien-8-ynoic acid isobutylamide

C18H27NO (273.2093)


   

2,4,8,11-Tetradecatetraenoic acid|tetradeca-2E,4E,8Z,11Z-tetraenoic acid pyrrolidide

2,4,8,11-Tetradecatetraenoic acid|tetradeca-2E,4E,8Z,11Z-tetraenoic acid pyrrolidide

C18H27NO (273.2093)


   

mirabilin H

mirabilin H

C17H27N3 (273.2205)


   
   

mirabilin A

mirabilin A

C17H27N3 (273.2205)


   

2,4-Tetradecadien-8-ynoic acid pyrrolidide|tetrradeca-2E,4E-dien-8-ynoic acid pyrrolidide

2,4-Tetradecadien-8-ynoic acid pyrrolidide|tetrradeca-2E,4E-dien-8-ynoic acid pyrrolidide

C18H27NO (273.2093)


   
   
   

gamma-Sanshool

gamma-Sanshool

C18H27NO (273.2093)


An enamide obtained by the formal condensation of 2-methylpropanamine with tetradeca-2,4,8,10,12-pentaenoic acid (the 2E,4E,8Z,10E,12E stereoisomer). Isolated from Zanthoxylum piperitum, it exhibits inhibitory activity against acyl-CoA:cholesterol acyltransferase.

   

Fenpropidin

Fenpropidin

C19H31N (273.2456)


D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 2958

   

Lauryldiethanolamine

N-Lauryldiethanolamine

C16H35NO2 (273.2668)


CONFIDENCE standard compound; INTERNAL_ID 308; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9028; ORIGINAL_PRECURSOR_SCAN_NO 9026 CONFIDENCE standard compound; INTERNAL_ID 308; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9043; ORIGINAL_PRECURSOR_SCAN_NO 9041 CONFIDENCE standard compound; INTERNAL_ID 308; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9061; ORIGINAL_PRECURSOR_SCAN_NO 9060 CONFIDENCE standard compound; INTERNAL_ID 308; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9075; ORIGINAL_PRECURSOR_SCAN_NO 9070 CONFIDENCE standard compound; INTERNAL_ID 308; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9047; ORIGINAL_PRECURSOR_SCAN_NO 9045 CONFIDENCE standard compound; INTERNAL_ID 308; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9097; ORIGINAL_PRECURSOR_SCAN_NO 9096

   

(E)-8-(but-3-en-1-yl)-5-(hepta-4,6-dien-1-yl)octahydroindolizine

(E)-8-(but-3-en-1-yl)-5-(hepta-4,6-dien-1-yl)octahydroindolizine

C19H31N (273.2456)


   

(5R,6R,8R)-6,8-dimethyl-5-((E)-non-6-en-8-yn-1-yl)octahydroindolizine

(5R,6R,8R)-6,8-dimethyl-5-((E)-non-6-en-8-yn-1-yl)octahydroindolizine

C19H31N (273.2456)


   

10Z,13Z,16Z-nonadecatrienenitrile

10Z,13Z,16Z-nonadecatrienenitrile

C19H31N (273.2456)


   

g-Sanshool

(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO (273.2093)


   

Margaric acid(d3)

Heptadecanoic acid(d3)

C17H31D3O2 (273.2747)


   

CAR 7:0

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


   

NA 18:5

(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO (273.2093)


   

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

C14H11D8NO4 (273.1816)


   

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

C16H24BNO2 (273.19)


   

9-((tert-Butoxycarbonyl)amino)nonanoic acid

9-((tert-Butoxycarbonyl)amino)nonanoic acid

C14H27NO4 (273.194)


   

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

C16H24BNO2 (273.19)


   

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

C14H27NO4 (273.194)


   

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

C16H24BNO2 (273.19)


   

N-BIS(TERT-BUTYLPROPIONATE)AMINE

N-BIS(TERT-BUTYLPROPIONATE)AMINE

C14H27NO4 (273.194)


   

octan-1-amine,octanoic acid

octan-1-amine,octanoic acid

C16H35NO2 (273.2668)


   

1-(Triisopropylsilyl)-1H-indole

1-(Triisopropylsilyl)-1H-indole

C17H27NSi (273.1913)


   

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

C14H27NO4 (273.194)


   

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.194)


   

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

C18H24FN (273.1893)


   

2-Benzyl-8,8-dimethyl-9-oxa-2-azaspiro[5.5]undecane

2-Benzyl-8,8-dimethyl-9-oxa-2-azaspiro[5.5]undecane

C18H27NO (273.2093)


   

4-methoxyphencyclidine , 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine

4-methoxyphencyclidine , 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine

C18H27NO (273.2093)


   

Tetrapropylammonium tetrafluoroborate

Tetrapropylammonium tetrafluoroborate

C12H28BF4N (273.2251)


   

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

C18H25O2- (273.1854)


   

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.194)


   

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

C16H23N3O (273.1841)


   

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

C16H23N3O (273.1841)


   

1,3-DI-TERT-BUTYL-2-(TERT-BUTYLAMINO)-1,

1,3-DI-TERT-BUTYL-2-(TERT-BUTYLAMINO)-1,

C12H31N3Si2 (273.2056)


   

7,7-azanediyldiheptanoic acid

7,7-azanediyldiheptanoic acid

C14H27NO4 (273.194)


   

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

C16H24BNO2 (273.19)


   

octanoic acid, compound with dibutylamine (1:1)

octanoic acid, compound with dibutylamine (1:1)

C16H35NO2 (273.2668)


   

Heptadecanoic-17,17,17-d3 Acid

Heptadecanoic-17,17,17-d3 Acid

C17H31D3O2 (273.2747)


   

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

C16H24BNO2 (273.19)


   

1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-pentacosadeuteriododecane

1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-pentacosadeuteriododecane

C12BrD25 (273.2709)


   

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

C16H23N3O (273.1841)


   

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

C15H23N5 (273.1953)


   

N-[2-[hydroxy(nitroso)amino]-3-methylbutyl]octanamide

N-[2-[hydroxy(nitroso)amino]-3-methylbutyl]octanamide

C13H27N3O3 (273.2052)


   
   

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

C16H23N3O (273.1841)


   

5,6-Dimethyl-1-octyl-4-benzimidazolamine

5,6-Dimethyl-1-octyl-4-benzimidazolamine

C17H27N3 (273.2205)


   

(9Z,12Z,15Z)-octadecatrien-6-ynoate

(9Z,12Z,15Z)-octadecatrien-6-ynoate

C18H25O2- (273.1854)


   

4-Methylhexanoylcarnitine

4-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

5-Methylhexanoylcarnitine

5-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

3-Methylhexanoylcarnitine

3-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

N-Decanoyl-L-Homoserine

N-Decanoyl-L-Homoserine

C14H27NO4 (273.194)


   

(S)-fenpropidin

(S)-fenpropidin

C19H31N (273.2456)


   

(R)-fenpropidin

(R)-fenpropidin

C19H31N (273.2456)


   
   

N-dodecanoyl-(2S)-hydroxyglycine

N-dodecanoyl-(2S)-hydroxyglycine

C14H27NO4 (273.194)


   

N-Octylbis(trimethylsilyl)amine

N-Octylbis(trimethylsilyl)amine

C14H35NSi2 (273.2308)


   

N-(1,3-dihydroxytridecan-2-yl)acetamide

N-(1,3-dihydroxytridecan-2-yl)acetamide

C15H31NO3 (273.2304)


   

2-(N-Methylamino)-3,7,11-trimethyl-1,3-dodecanediol

2-(N-Methylamino)-3,7,11-trimethyl-1,3-dodecanediol

C16H35NO2 (273.2668)


   

N-(1,3-dihydroxynonan-2-yl)hexanamide

N-(1,3-dihydroxynonan-2-yl)hexanamide

C15H31NO3 (273.2304)


   

N-(1,3-dihydroxyoctan-2-yl)heptanamide

N-(1,3-dihydroxyoctan-2-yl)heptanamide

C15H31NO3 (273.2304)


   

N-(1,3-dihydroxydodecan-2-yl)propanamide

N-(1,3-dihydroxydodecan-2-yl)propanamide

C15H31NO3 (273.2304)


   

N-(1,3-dihydroxydecan-2-yl)pentanamide

N-(1,3-dihydroxydecan-2-yl)pentanamide

C15H31NO3 (273.2304)


   

N-(1,3-dihydroxyundecan-2-yl)butanamide

N-(1,3-dihydroxyundecan-2-yl)butanamide

C15H31NO3 (273.2304)


   

N-Para-octylphenyl-2-pyrrolidone

N-Para-octylphenyl-2-pyrrolidone

C18H27NO (273.2093)


   

N-Isobutyl-2,4,8,10,12-tetradecapentaenamide

N-Isobutyl-2,4,8,10,12-tetradecapentaenamide

C18H27NO (273.2093)


   

O-heptanoylcarnitine

O-heptanoylcarnitine

C14H27NO4 (273.194)


An O-acylcarnitine that is the O-heptanoyl derivative of carnitine.

   

Sphingosine (d16:0)

SPH(d16:0)

C16H35NO2 (273.2668)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine

1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine

C18H27NO (273.2093)


   

NA-Ser 11:0

NA-Ser 11:0

C14H27NO4 (273.194)


   

NA-Thr 10:0

NA-Thr 10:0

C14H27NO4 (273.194)


   

Cevimeline (hydrochloride hemihydrate)

Cevimeline (hydrochloride hemihydrate)

C10H17NOS.HCl.1/2H2O (273.2468)


Cevimeline hydrochloride hemihydrate (SNI-2011) is a quinuclidine derivative of acetylcholine and a selective and orally active muscarinic M1 and M3 receptor agonist. Cevimeline hydrochloride hemihydrate stimulates secretion by the salivary glands and can be used as a sialogogue for xerostomia[1][2][3][4]. Cevimeline hydrochloride hemihydrate can cross the blood-brain barrier (BBB)[5].

   

(1s,4s,10r,12r)-9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

(1s,4s,10r,12r)-9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

C17H27N3 (273.2205)


   

1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

C18H27NO (273.2093)


   

n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

C18H27NO (273.2093)


   

(2e,4e)-1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

(2e,4e)-1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

C18H27NO (273.2093)


   

n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2093)


   

n-[(2s)-2-[hydroxy(nitroso)amino]-3-methylbutyl]octanimidic acid

n-[(2s)-2-[hydroxy(nitroso)amino]-3-methylbutyl]octanimidic acid

C13H27N3O3 (273.2052)


   

5-(7-methylnonyl)-1,2,3,4-tetrahydroquinoline

5-(7-methylnonyl)-1,2,3,4-tetrahydroquinoline

C19H31N (273.2456)


   

(2e,4e,8z,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2093)


   

(2e,4e,8z,11z)-1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

(2e,4e,8z,11z)-1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

C18H27NO (273.2093)


   

(2e,4e,8z,10e,12e)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2093)


   

5-decyl-1,2,3,4-tetrahydroquinoline

5-decyl-1,2,3,4-tetrahydroquinoline

C19H31N (273.2456)


   

(2e,6e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,6,8,10,12-pentaenimidic acid

(2e,6e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,6,8,10,12-pentaenimidic acid

C18H27NO (273.2093)


   

9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H27N3 (273.2205)


   

(1s,4s,10s,12r)-9-[(1e)-hex-1-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

(1s,4s,10s,12r)-9-[(1e)-hex-1-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

C17H27N3 (273.2205)


   

5-(8-methylnonyl)-1,2,3,4-tetrahydroquinoline

5-(8-methylnonyl)-1,2,3,4-tetrahydroquinoline

C19H31N (273.2456)


   

(1s,4s,10r,12r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

(1s,4s,10r,12r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

C17H27N3 (273.2205)


   

n-{2-[hydroxy(nitroso)amino]-3-methylbutyl}octanimidic acid

n-{2-[hydroxy(nitroso)amino]-3-methylbutyl}octanimidic acid

C13H27N3O3 (273.2052)


   

(2e,4e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2093)


   

(2e)-n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

(2e)-n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

C18H27NO (273.2093)


   

(z)-(hydroxyimino)({1-[(1-hydroxyoctylidene)amino]-3-methylbutan-2-yl})oxidoazanium

(z)-(hydroxyimino)({1-[(1-hydroxyoctylidene)amino]-3-methylbutan-2-yl})oxidoazanium

C13H27N3O3 (273.2052)


   

1-(4-isopropylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one

1-(4-isopropylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one

C18H27NO (273.2093)


   

(2e,4e,10z)-n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

(2e,4e,10z)-n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

C18H27NO (273.2093)


   

1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

C18H27NO (273.2093)


   

n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

C18H27NO (273.2093)


   

(1s,9r,10r)-9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

(1s,9r,10r)-9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H27N3 (273.2205)